Pre‐clinical validation of a selective anti‐cancer stem cell therapy for Numb‐deficient human breast cancers
Daniela Tosoni(University of Milan), Salvatore Pece(University of Milan)
Cited by 44
Related Papers
CDK12 promotes tumorigenesis but induces vulnerability to therapies inhibiting folate one-carbon metabolism in breast cancer
|Nature Communications|2022|43
Loss of NUMB drives aggressive bladder cancer via a RHOA/ROCK/YAP signaling axis
|Nature Communications|2024|9
Mechanisms of active wetting and fluidification in epithelial cell collectives
|Nature Materials|2026|2